These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 22784115)

  • 1. Potassium channel KIR4.1 as an immune target in multiple sclerosis.
    Srivastava R; Aslam M; Kalluri SR; Schirmer L; Buck D; Tackenberg B; Rothhammer V; Chan A; Gold R; Berthele A; Bennett JL; Korn T; Hemmer B
    N Engl J Med; 2012 Jul; 367(2):115-23. PubMed ID: 22784115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potassium channel KIR4.1-specific antibodies in children with acquired demyelinating CNS disease.
    Kraus V; Srivastava R; Kalluri SR; Seidel U; Schuelke M; Schimmel M; Rostasy K; Leiz S; Hosie S; Grummel V; Hemmer B
    Neurology; 2014 Feb; 82(6):470-3. PubMed ID: 24415573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Kir4.1 Antibodies in Multiple Sclerosis: Specificity and Pathogenicity.
    Imamura M; Higuchi O; Maeda Y; Mukaino A; Ueda M; Matsuo H; Nakane S
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study.
    Brickshawana A; Hinson SR; Romero MF; Lucchinetti CF; Guo Y; Buttmann M; McKeon A; Pittock SJ; Chang MH; Chen AP; Kryzer TJ; Fryer JP; Jenkins SM; Cabre P; Lennon VA
    Lancet Neurol; 2014 Aug; 13(8):795-806. PubMed ID: 25008548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential loss of KIR4.1 immunoreactivity in multiple sclerosis lesions.
    Schirmer L; Srivastava R; Kalluri SR; Böttinger S; Herwerth M; Carassiti D; Srivastava B; Gempt J; Schlegel J; Kuhlmann T; Korn T; Reynolds R; Hemmer B
    Ann Neurol; 2014 Jun; 75(6):810-28. PubMed ID: 24777949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of confirmation of anti-inward rectifying potassium channel 4.1 antibodies as reliable markers of multiple sclerosis.
    Nerrant E; Salsac C; Charif M; Ayrignac X; Carra-Dalliere C; Castelnovo G; Goulabchand R; Tisseyre J; Raoul C; Eliaou JF; Labauge P; Vincent T
    Mult Scler; 2014 Nov; 20(13):1699-703. PubMed ID: 24756568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced accumulation of Kir4.1 protein, but not mRNA, in a murine model of cuprizone-induced demyelination.
    Nakajima M; Kawamura T; Tokui R; Furuta K; Sugino M; Nakanishi M; Okuyama S; Furukawa Y
    Brain Res; 2013 Nov; 1537():340-9. PubMed ID: 24070676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low reliability of anti-KIR4.1
    Marino M; Frisullo G; Di Sante G; Samengo DM; Provenzano C; Mirabella M; Pani G; Ria F; Bartoccioni E
    Mult Scler; 2018 Jun; 24(7):910-918. PubMed ID: 28548026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease mechanisms in MS: the potassium channel KIR4.1--a potential autoantigen in MS.
    Racke MK
    Nat Rev Neurol; 2012 Nov; 8(11):595-6. PubMed ID: 22986435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of KIR4.1 as an Immune Target in Multiple Sclerosis.
    Chastre A; Hafler DA; O'Connor KC
    N Engl J Med; 2016 Apr; 374(15):1495-6. PubMed ID: 27074083
    [No Abstract]   [Full Text] [Related]  

  • 11. Humoral Responses to Diverse Autoimmune Disease-Associated Antigens in Multiple Sclerosis.
    Malyavantham K; Weinstock-Guttman B; Suresh L; Zivadinov R; Shanahan T; Badgett D; Ramanathan M
    PLoS One; 2015; 10(6):e0129503. PubMed ID: 26065913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased anti-KIR4.1 antibodies in multiple sclerosis: could it be a marker of disease relapse?
    Brill L; Goldberg L; Karni A; Petrou P; Abramsky O; Ovadia H; Ben-Hur T; Karussis D; Vaknin-Dembinsky A
    Mult Scler; 2015 Apr; 21(5):572-9. PubMed ID: 25392324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple Sclerosis and Antibodies against KIR4.1.
    Pröbstel AK; Kuhle J; Lecourt AC; Vock I; Sanderson NS; Kappos L; Derfuss T
    N Engl J Med; 2016 Apr; 374(15):1496-8. PubMed ID: 27074084
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of potassium channel KIR4.1 antibodies in Multiple Sclerosis patients.
    Marnetto F; Valentino P; Caldano M; Bertolotto A
    J Immunol Methods; 2017 Jun; 445():53-58. PubMed ID: 28300540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to potassium channels in multiple sclerosis.
    Cross AH; Waubant E
    N Engl J Med; 2012 Jul; 367(2):172-4. PubMed ID: 22784120
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-KIR4.1 Antibodies in Chinese Patients with Central Nervous System Inflammatory Demyelinating Disorders.
    Zhong R; Liang J; Tao A; Wu L; Yang X; Xu H; Huang Q; Zhuang S; Long Y; Gao C
    Neuroimmunomodulation; 2016; 23(5-6):295-300. PubMed ID: 28391264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of antibodies against KIR4.1 in multiple sclerosis: A three-technique approach and systematic review.
    Navas-Madroñal M; Valero-Mut A; Martínez-Zapata MJ; Simón-Talero MJ; Figueroa S; Vidal-Fernández N; López-Góngora M; Escartín A; Querol L
    PLoS One; 2017; 12(4):e0175538. PubMed ID: 28414733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to the inward rectifying potassium channel 4.1 in multiple sclerosis: different methodologies--conflicting results?
    Hemmer B
    Mult Scler; 2015 Apr; 21(5):537-9. PubMed ID: 25583849
    [No Abstract]   [Full Text] [Related]  

  • 19. Aglycosylated extracellular loop of inwardly rectifying potassium channel 4.1 (KCNJ10) provides a target for autoimmune neuroinflammation.
    Nicot AB; Harb J; Garcia A; Guillot F; Mai HL; Mathé CV; Morille J; Vallino A; Dugast E; Shah SP; Lefrère F; Moyon M; Wiertlewski S; Le Berre L; Renaudin K; Soulillou JP; van Pesch V; Brouard S; Berthelot L; Laplaud DA
    Brain Commun; 2023; 5(2):fcad044. PubMed ID: 36910419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potassium channel Kir4.1 associates with the dystrophin-glycoprotein complex via alpha-syntrophin in glia.
    Connors NC; Adams ME; Froehner SC; Kofuji P
    J Biol Chem; 2004 Jul; 279(27):28387-92. PubMed ID: 15102837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.